Diagnostic options · UAE

AML Panel tests in Dubai & UAE

Compare available AML Panel tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

AML Panel test prices

Showing 1–1 of 1 matching tests.

AML Panel diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1850 AML Prognostic Panel (Cytogenetics + PCR) Test This test evaluates for key chromosomal abnormalities and gene mutations associated with Acute Myeloid Leukemia (AML) to determine risk stratification.	Bone Marrow Aspirate (preferred) / Peripheral Blood (alternative)	5–7 working days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Structural chromosomal rearrangements (e.g., AML1-ETO, INV(16), PML-RARA)", "Gene mutations (e.g., FLT3-ITD/TKD, NPM1, CEBPA)"] Parameters [{"name": "Karyotype", "reference_range": "Normal human karyotype (46,XX or 46,XY)"}, {"name": "AML1-ETO (RUNX1-RUNX1T1) Fusion", "reference_range": "Negative / Positive"}, {"name": "CBFB-MYH11 (INV(16)) Fusion", "reference_range": "Negative / Positive"}, {"name": "PML-RARA Fusion", "reference_range": "Negative / Positive"}, {"name": "FLT3-ITD Mutation", "reference_range": "Negative / Positive (Allele burden reported if positive)"}, {"name": "FLT3-TKD Mutation", "reference_range": "Negative / Positive"}, {"name": "NPM1 Mutation", "reference_range": "Negative / Positive"}, {"name": "CEBPA Mutation", "reference_range": "Negative / Positive (Biallelic status reported)"}] Preparation ["No specific fasting required.", "Inform the physician of all current medications."] Indications ["Diagnosis of Acute Myeloid Leukemia (AML)", "Risk stratification for treatment planning", "Prognostic assessment", "Eligibility assessment for clinical trials"] Measurement technique Confirm with laboratory Codes LOINC: 88277-7 ICD-10: C92.0 Clinical summary This test evaluates for key chromosomal abnormalities and gene mutations associated with Acute Myeloid Leukemia (AML) to determine risk stratification.

Category overview

AML Panel: overview

Facing a complex blood cancer diagnosis requires precise answers, and uncovering the exact molecular profile offers a powerful foundation for smarter care. As part of our Molecular Diagnostics division, our AML Panel utilizes advanced next-generation sequencing to simultaneously analyze critical genetic mutations associated with acute myeloid leukemia. Rather than delivering a final standalone diagnosis, this detailed AML panel data empowers your hematologist-oncologist with the crucial insights needed for highly customized, proactive medical guidance and targeted treatments. Trusted as one of the leading diagnostic labs in Dubai and the UAE, DNA Labs UAE prioritizes rigorous patient confidentiality alongside incredibly swift, precise turnaround times. Empower your targeted hematology strategy: review our AML panel testing in the UAE below to book your test, schedule a gentle home collection, or contact our dedicated specialists.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.